Rebecca Chambers
CIK 1823563 · Chief Financial Officer · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.35M
Companies
4
Total Filings
50
Lifetime Open-Market Net
-$6.10M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VCYT | Chief Financial Officer | 176,841 | $47.22 | $8.35M | -$2.66M | 29 | 2026-06-04 |
| ALMR | Director | — | $28.46 | — | $0 | 1 | 2026-04-20 |
| Inari Medical, Inc. (NARI) Delisted | Director | 0 | $79.97 | $0 | -$55.7K | 7 | 2025-02-19 |
| OM | Chief Financial Officer | 906 | $4.90 | $4.4K | -$3.39M | 6 | 2021-06-25 |
Recent Filings · Page 3 of 5
50 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-14 | VCYT | Sell (S) | −15,275 | -$585.7K | EDGAR |
| 2024-11-12 | VCYT | Notice (144) | −15,275 | -$594.0K | EDGAR |
| 2024-09-04 | VCYT | Tax (F) | −3,464 | -$109.3K | EDGAR |
| 2024-06-24 | Inari Medical, Inc. (NARI) Delisted | Sell (S) | −260 | -$12.0K | EDGAR |
| 2024-06-04 | VCYT | Tax (F) | −3,462 | -$71.8K | EDGAR |
| 2024-05-21 | Inari Medical, Inc. (NARI) Delisted | Sell (S) | −964 | -$43.8K | EDGAR |
| 2024-05-20 | — | Notice (144) | −1,224 | -$56.0K | EDGAR |
| 2024-04-26 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +4,126 | $175.0K | EDGAR |
| 2024-03-19 | VCYT | Mixed | +2,129 | -$46.2K | EDGAR |
| 2024-03-08 | VCYT | Grant (A) | +59,856 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.